Skip to content

Study by DB Fernverkehr AG on corona infections and corona immunity of its employees (COVID-19)

Study by DB Fernverkehr AG on corona infections and corona immunity of its employees (COVID-19)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00022359
Enrollment
1050
Registered
2020-07-17
Start date
2020-06-29
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid-19

Interventions

Group 1: train attendants
will undergo two SARS-CoV-2 tests at each visit: a PCR-test to identify active SARS-CoV-2 infections as well as an IgG-antibody-test to detect past SARS-CoV-2 infections. Tests will be repeated in aut

Sponsors

DB Fernverkehr AG
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Railway employees (train attendants / train drivers / craftsmen)

Exclusion criteria

Exclusion criteria: none

Design outcomes

Secondary

MeasureTime frame
Exploration of infection rates with underlying epidemiological factors

Primary

MeasureTime frame
prevalence and incidence of acute Covid-19 infections and seropositivity

Countries

Germany

Contacts

Public ContactChristian Gravert

Deutsche Bahn AG

Christian.Gravert@deutschebahn.com+49 30 297 61399

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026